Call for Abstract
Scientific Program
European Virtual Congress on Hematology, will be organized around the theme “Understand the pathophysiology of hematologic diseases & improve their outcomes”
Hematology Congress is comprised of 25 tracks and 121 sessions designed to offer comprehensive sessions that address current issues in Hematology Congress.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
The word Heme came from Greek which means blood. Hematology involves the diagnosis and treatment of patients who have disorders of the blood and bone marrow. It is mainly responsible for the diagnosis of benign and malignant disorders of the red and white blood cells, platelets and the coagulation system in adults and children. Blood disorders are conditions that impact the blood's ability to function correctly; their patients may have a serious life- threatening illness such as leukemia, lymphoma or myeloma that requires chemotherapy.
- Track 1-1Genetics of Blood Cells
- Track 1-2Blood Physiology
- Track 1-3Etiology of Blood
- Track 1-4Hemoglobin
- Track 1-5Blood vessels
Hematology oncology is the most important part of Hematology research, a major part of blood based researches is carried out in this field. The cancer which originates from white blood cells are called as lymphoma and this disorder is mainly seen in Hodgkin lymphoma these diseases are treated by radiation and chemotherapy, or hematopoietic stem cell transplantation. The cancer which starts with in the cell is called as Non Hodgkin lymphocytes and these lymphocytes are of lymph nodes. The bone marrow which develops too many white blood cells leads to multiple myeloma.
- Track 2-1Myeloid Leukemias
- Track 2-2Myelodysplastic Syndromes
- Track 2-3Lymphomas
- Track 2-4Chronic Lymphocytic Leukemia
- Track 2-5Multiple Myeloma
Blood transfusion is the process of receiving whole blood or blood products into one’s systemic circulation intravenously. Blood transfusion is usually done in cases of deficiencies, to increase the oxygen saturation, during accidents or during surgery, to treat hematologic conditions such as severe anemia, leukemia, and sickle cell disease. Transfusion may include injection of whole blood or components such as red blood cells, white blood cells, plasma, platelets or clotting factors. Research and Development in this area of Hematology is hence considered a very important aspect.
- Track 3-1Components of Blood
- Track 3-2Grouping and Cross matching
- Track 3-3Type of Blood Transfusion
- Track 3-4Complications of Blood Transfusion
Haemorrhage disorders are incited by vascular malformation or deficiency. They are linked with cutaneous or mucosal flat or perceptible purpura. These disorders are a heterogeneous assembly of circumstances categorized by easy staining, petechiae, mucosal bleeding, bruise, and impulsive hemorrhage from small vessels. The fundamental imperfection is stated to be moreover in the vessels themselves or in the perivascular connective tissue. The commonly used purpura usually describes subcutaneous bleeding, which will be linked to vessel wall abnormalities or platelet abnormalities of which some are hereditary and while the others are acquired.
- Track 4-1Autoerythrocyte Sensitization
- Track 4-2Dysproteinemias Causing Vascular Purpura
- Track 4-3Hereditary Hemorrhagic Telangiectasia
- Track 4-4Purpura Simplex
- Track 4-5Senile Purpura
Biomarkers are the biological molecules found in blood, other body fluids, or tissues, which explains a symbol of a normal or anomalous progression, or of a condition or illness. These are used to see how well the body answers to a therapy for an illness or disorder. These are also defined as molecular marker and signature molecule. A cancer biomarker is a gene or substance that detects the occurrence of cancer in the body that are particularly associated with genetic mutations, which determine whether individuals are susceptible to particular type of cancer.
- Track 5-1Cancer biomarker
- Track 5-2Genetic biomarker
- Track 5-3Diagnosis biomarker
- Track 5-4Tumor biomarker
Currently pharmaceutical firms are involved in the main specializing in Recombinant, genetically engineered pharmaceuticals which may be smart alternative for treatment. If you have got a gentle form of hemophilia, a medicine referred to as desmopressin acetate (DDAVP) will briefly increase the concentration of factor VIII in your blood. DDAVP may be given intravenously, through an injection, or within the type of nasal spray. Antifibrinolytic medicines like tranexamic acid and epsilon aminocaproic acid are that are typically used with replacement therapy to assist keep blood clots from breaking down.
- Track 6-1Clinical trials
- Track 6-2Drug Repurposing
- Track 6-3Patient-reported outcomes in drug development
- Track 6-4Hematopoietic cells Mobilization
Blood disorders affect one or more parts of the blood and prevents blood from doing its job. They can be acute or chronic. Many blood disorders are inherited. Other causes include other diseases, side effects of medicines, and a lack of certain nutrients in your diet. Types of blood disorders include Platelet disorders, excessive clotting, and bleeding problems, anemia, leukemia , myeloma and eosinophilic disorders.
- Track 7-1Anemia
- Track 7-2Coagulopathies
- Track 7-3Hemostasis
- Track 7-4HIV/AIDS
- Track 7-5Leukemia
Hematology-oncology is the science applied to treat blood disorders and diseases like cancers (oncology). Also, it treats with blood cancers and some disease includes iron deficiency anemia, thalassemia’s as well other organ cancers. The treatment will vary for individual suffering with myeloma based on many factors, in this multiple myeloma it includes a stage referred smoldering stage in which it doesn’t show active symptoms that is the state in which myeloma cells present in the body were not progressive.
- Track 8-1Acute Lymphocytic Leukemia
- Track 8-2Lymphomas
- Track 8-3Bone Tumors
- Track 8-4Myeloproliferative Disorders
- Track 8-5Acute Myelogenous Leukemia
Clinical and Experimental Medicine publishes reports of clinical and experimental work concerned with the following fields: clinical chemistry, hematology, immunology, oncology and virology. The major criteria for publication will be clarity, experimental soundness and advances in knowledge. Papers containing new clinical or experimental data, are likely to contribute to changes in clinical practice in thinking about a disease will be given priority due to their immediate importance.
- Track 9-1Pediatric Hematology
- Track 9-2Chemotherapy
- Track 9-3Hematocrit
- Track 9-4Fibrinolytic Enzymes
- Track 9-5Sedimentation
The umbilical cord is a conduit between the developing embryo or fetus and the placenta. The umbilical vein supplies the fetus with nutrient-rich blood from the placenta. Thrombosis is the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system. The hemostatic is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel this is the first stage of wound healing.
- Track 10-1Bone marrow Transplantation
- Track 10-2Platelet plug
- Track 10-3Coagulation
- Track 10-4Venous Thromboembolism
- Track 10-5Thrombophlebitis
Immunohematology is referred to as blood managing an account also, is a branch of Hematology which contemplates antigen-counter acting agent responses and comparative wonders as they identify with the pathogenesis and clinical indications of blood issue. Individuals working in this field are noted to as an immuno-hematologist. Individuals may be vaccinated to RBCs due to earlier contact to RBCs of different people, as often as possible through pregnancy or transfusion.
- Track 11-1Human Transplantation Antigens
- Track 11-2Lewis Blood Group system
- Track 11-3Antibody Formation
- Track 11-4Immunochemistry of antigens
- Track 11-5Molecular Immunohematology
Pediatric Hematology covers all aspects of pediatric hematology and oncology. It includes immunology, pathology, and pharmacology in relation to blood diseases and cancer in children and shows how basic experimental research can contribute to the understanding of clinical problems. Physicians who work in hematology laboratories, and most commonly manage them, are pathologists specialized in the diagnosis of hematological diseases, referred to as hematopathologists or hematopathologists.
- Track 12-1Immunology
- Track 12-2Pathology
- Track 12-3Pediatric hematology
- Track 12-4Pharmacology
- Track 12-5Experimental Hematology
Hematologic cancer is the mostly spread and most common disorder among other Blood disorders and is a very important aspect of Blood disorder research. Blood malignancies affect the performance and formation of your blood cells. Cancerous cells restrict your blood from performing its important/regular functions, like prohibiting from serious bleeding or fighting with foreign body/infections agents. The bone marrow in which many white blood cells develop that leads to multiple myeloma.
- Track 13-1Leukemia
- Track 13-2Non-Hodgkin Lymphoma
- Track 13-3Hodgkin Lymphoma
- Track 13-4Multiple Myeloma
- Track 13-5Lymphoma
Blood Transfusion is a medical practice where donated blood is transfused to a recipient. It is a lifesaving, benign procedure. These are wont to treat several medical conditions like iron deficiency Anemia, red blood cell ailment, severe haemorrhage generally from surgery, childbirth, or a significant fate. There will be reform of transfusion facilities for healthier effectiveness and repair delivery. The number of blood banks will drop, and high-volume, technically up-clambered central blood banks will function in their place to diminish the prices of procedure.
- Track 14-1Metabolomics in Transfusion medicine
- Track 14-2Quality indicators for Transfusion medicine
- Track 14-3Molecular Diagnostics in Transfusion medicine
- Track 14-4Error reports in Transfusion medicine
- Track 14-5Blood Banking
Cancer genomics is a sub-field of genomics that personifies cancer-linked or cancer associated genes. Whereas Metabolomics is the quantification of small molecules formed by metabolic progressions within a biological model. Metabolomics datasets contain a wealth of data that reflect the disease state and are consequent to both genetic variation and environment. Because cancer is a genomic disease, genomic profiling is an undeniably important tool for precision oncology.
- Track 15-1Tumor Evolution
- Track 15-2Genomic heterogeneity
- Track 15-3Immunogenomics
- Track 15-4Tumor metabolism
- Track 15-5Predictive metabolic markers
One of three foundations of blood-forming cells used in transplants are Cord Blood whereas the other two bases are bone marrow and peripheral blood stem cells. Human cryopreserved CD34+ cells from cord blood, bone marrow, and Mobilized blood. CD34+ cells differentiate into all other white blood cells. The first successful cord blood transplant (CBT) was wiped out 1988 during a child with Fanconi Anemia. The theory of the learning is twofold unit umbilical cord blood transplantation in adults will relate to a one-year endurance rate of at least 40%.
- Track 16-1Cord Blood Hematopoiesis
- Track 16-2Umbilical Cord Transplantation
- Track 16-3Aplastic Anemia
- Track 16-4Thalassemia
- Track 16-5Immunogenetics in Cord Blood Transplantation
The channel of medicine that perturbed with the learning of the origin, diagnosis, therapy and anticipation of diseases related to blood. The test center slog that goes into the study of blood is recurrently performed by a medical technologist or medical laboratory scientist. Treating of blood disorder may differ for every particular disorder, this can include use of coagulation factor support, immune modulating therapies, chemotherapy, bone marrow transplantation palliative care must be taken for the patients with complex disorder.
- Track 17-1Clinical Diagnosis
- Track 17-2Pathological Diagnosis
- Track 17-3Full Blood Count
- Track 17-4Erythrocyte Sedimentation Rate
- Track 17-5Clotting Screen
Blood group antigens are polymorphic residues of protein or carbohydrate on the red cell surface. They can provoke an antibody response in individuals who lack them, and some antibodies can lead to hemolytic transfusion reaction or hemolytic disease of the fetus/newborn. Researchers have identified the molecular basis of many red cell blood group antigens, and an actively maintained database currently lists over 1,600 alleles of 44 genes.
- Track 18-1ABO –blood group typing
- Track 18-2Agglutination
- Track 18-3Synthetic receptors
- Track 18-4Molecular imprinting
- Track 18-5Serological testing
A blood substitute is a substance used to mimic and fulfill some functions of biological blood. It aims to provide an alternative to blood transfusion, which is transferring blood or blood-based products from one person into another. Pathogen reduction using riboflavin and UV light is a method by which infectious pathogens in blood for transfusion are inactivated by adding riboflavin and irradiating with UV light. This method reduces the infectious levels of disease-causing agents that may be found in donated blood components, while still maintaining good quality blood components for transfusion.
- Track 19-1Hemopoietic Stem Cell Transplant
- Track 19-2Cord Blood Banking
- Track 19-3Molecular Techniques
- Track 19-4Cryopreservation
- Track 19-5Haemonetics
A case report is usually considered a kind of anecdotal proof and a peer-referee Open Access journal that publishes case reports and case series in all areas of hematology, including general hematology and oncology, with a specific focus on lymphomas and leukemia and usually considered as a kind of anecdotal proof and Open Access journal that publishes case reports and case series in all areas of hematology, including general hematology and oncology, with a specific focus on lymphomas and leukemia.
- Track 20-1Hemophagocytic Lymphohistiocytocis
- Track 20-2Portal Vein Thrombosis
- Track 20-3Allogenic Stem Cell Transplantation
- Track 20-4Venous Thromboembolism
- Track 20-5Melanoma
The Center for Hematologic Oncology provides specialized care for all types of cancers of the blood, including leukemia, lymphoma, multiple myeloma, as well as related disorders of the blood, such as aplastic anemia and Myelodysplastic syndrome.
- Track 21-1Radiotherapy
- Track 21-2Cryotherapy
- Track 21-3Standard –Dose Chemotherapy
- Track 21-4Combined Chemotherapy and Radiotherapy
- Track 21-5Target Therapy
The crossing point amongst hematology and neurology is comprehensive, and neurological complications within the course of hematologic ailment are recurrent and diverse. Polycythemia, in which there are increased numbers of red blood cells with iron deficient. Haematological conditions that lead into neurological manifestations are Thrombophilia, antiphospholipid antibody syndrome, thrombotic thrombocytopenic purpura, sickle cell, myeloma, leukemias, lymphomas and clonal disorders.
- Track 22-1Transient cerebral ischemia
- Track 22-2Polycythaemia rubra Vera
- Track 22-3Paroxysmal Nocturnal Hemoglobinuria
- Track 22-4Waldonstrom’s macroglobulinemia
- Track 22-5Neuroimaging in Lymphoma
- Track 22-6Plasma cell dyscrasias
Developments in electronic imaging, computers, and the Internet have given rise to in the speedy emergence of digital imaging in pathology. The Bloodhound system is an instrument that's designed to print blood onto a slide with a controlled method, automatically stain cells, perform a CBC with WBC differential, and locate WBCs by digital imaging, all in an analyser with a footprint of 42 inches. Digital Imaging works in daily routine for leukocytes in peripheral blood and other fluids, is reliable, accurate and displays a high blast cell sensitity.
- Track 23-1Integrated digital hematology system
- Track 23-2Digital morphology
- Track 23-3Live image viewing
- Track 23-4Digital slides
Hematology medical attendants are the specialists in taking care of the patients with blood related infections. They realize patients' medical record , and that they will help the hematologist to analyse and treat the blood related illnesses. They can recommend the prescription as they know about the state of the condition. Keeping in mind the end goal to seek after the learning of hematology nursing, one must finish the recognition in nursing or four year college education in nursing and the massive feeling of certainty happens when they have the involvement in the particular field.
- Track 24-1Nursing research
- Track 24-2Surgical hematology nursing
- Track 24-3Clinical hematology nursing
- Track 24-4Medical Oncology nursing
Paediatric haematology is a branch of haematology dealing with the general haematological problems seen in neonates or paediatric patients. Other issues like blood counts, Polycythaemia, Neonatal anaemia, Anaemia of prematurity, hemolytic anemia within the neonate, Congenital red cell defects, acquired red cell defects, Hyper bilirubinemia, Congenital dyserythropoietic anaemia, Acquired red cell aplasia, Neutropenia, leukaemia etc are dealt under Paediatric Haematology.
- Track 25-1Neonatal Bleeding and Thrombotic Disorders
- Track 25-2Childhood Leukemia
- Track 25-3Acanthocytosis
- Track 25-4Immune Thrombocytopenic Purpura in Children
- Track 25-5Aplastic Anemia